Positive News Sentiment NASDAQ:MBOT Microbot Medical Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $5.01 -0.12 (-2.34%) (As of 07/1/2022 12:00 AM ET) Add Compare Share Today's Range$4.83▼$5.1550-Day Range$4.71▼$6.1752-Week Range$4.31▼$9.60Volume5,499 shsAverage Volume84,192 shsMarket Capitalization$35.61 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Microbot Medical Stock Forecast (MarketRank)Analyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.73% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.85) to ($1.53) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.86 out of 5 starsMedical Sector1185th out of 1,429 stocksBiological Products, Except Diagnostic Industry184th out of 217 stocks 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Microbot Medical. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.73% of the float of Microbot Medical has been sold short.Short Interest Ratio / Days to CoverMicrobot Medical has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Microbot Medical has recently decreased by 8.59%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MBOT. Previous Next 3.3 News and Social Media Coverage News SentimentMicrobot Medical has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Microbot Medical this week, compared to 0 articles on an average week.Search InterestOnly 2 people have searched for MBOT on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by Insiders10.76% of the stock of Microbot Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 11.45% of the stock of Microbot Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Microbot Medical are expected to grow in the coming year, from ($1.85) to ($1.53) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Microbot Medical is -3.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Microbot Medical is -3.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMicrobot Medical has a P/B Ratio of 2.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address About Microbot Medical (NASDAQ:MBOT)Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.Read More MBOT Stock News HeadlinesJune 10, 2022 | americanbankingnews.comMicrobot Medical (NASDAQ:MBOT) Stock Price Crosses Above Two Hundred Day Moving Average of $5.76May 25, 2022 | finance.yahoo.com11 Best Robotics Stocks Under $10April 11, 2022 | apnews.comMicrobot Medical to Review Recent Progress During Needham’s Virtual Healthcare ConferenceApril 6, 2022 | benzinga.comMicrobot Medical Promotes Rachel Vaknin To Chief Financial OfficerApril 6, 2022 | seekingalpha.comMicrobot Medical promotes Rachel Vaknin to CFOApril 6, 2022 | finance.yahoo.comMicrobot Medical Continues to Strengthen Management Team as Rachel Vaknin Promoted to Chief Financial OfficerMarch 31, 2022 | finance.yahoo.comMicrobot Medical Achieves Significant Regulatory Milestone for the LIBERTY® Robotic System; Files FDA Pre-Submission Package for Regulatory PathwayMarch 15, 2022 | nasdaq.comPre-market Movers: IXHL, COUP, MGLD, AGRI, EVLV…February 1, 2022 | finance.yahoo.comShort Squeeze Stocks: PIXY, MBOT and 3 Others Experts Think Are Ready to PopDecember 28, 2021 | msn.comWhy Microbot Medical Shares Are Sliding TodayDecember 28, 2021 | finance.yahoo.comCompany News for Dec 28, 2021December 27, 2021 | finance.yahoo.comMicrobot Medical Surges On Stryker CollaborationDecember 27, 2021 | markets.businessinsider.comMid-Afternoon Market Update: Dow Surges Over 200 Points; Microbot Medical Shares Spike HigherSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MBOT CUSIPN/A CIK883975 Webwww.microbotmedical.com Phone(781) 875-3605Fax781-556-5347Employees14Year Founded2010Company Calendar Last Earnings11/15/2021Today7/02/2022Next Earnings (Estimated)8/15/2022Fiscal Year End12/31/2022Profitability EPS (Most Recent Fiscal Year)($1.420010) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11.31 million Net MarginsN/A Pretax MarginN/A Return on Equity-75.72% Return on Assets-67.29% Debt Debt-to-Equity RatioN/A Current Ratio7.61 Quick Ratio7.61 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.02 per share Price / Book2.48Miscellaneous Outstanding Shares7,108,000Free Float6,343,000Market Cap$35.61 million OptionableNot Optionable Beta3.99 Social Links Microbot Medical Frequently Asked Questions How has Microbot Medical's stock performed in 2022? Microbot Medical's stock was trading at $7.50 at the beginning of the year. Since then, MBOT shares have decreased by 33.2% and is now trading at $5.01. View the best growth stocks for 2022 here. When is Microbot Medical's next earnings date? Microbot Medical is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022. View our earnings forecast for Microbot Medical. How were Microbot Medical's earnings last quarter? Microbot Medical Inc. (NASDAQ:MBOT) released its earnings results on Monday, November, 15th. The biotechnology company reported ($0.36) EPS for the quarter, meeting the consensus estimate of ($0.36). View Microbot Medical's earnings history. When did Microbot Medical's stock split? How did Microbot Medical's stock split work? Microbot Medical shares reverse split before market open on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split. Who are Microbot Medical's key executives? Microbot Medical's management team includes the following people: Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 49, Pay $813.8k)Mr. Yoseph Bornstein, CO-Founder & Independent Director (Age 63, Pay $52.5k)Dr. Simon Sharon MBA, MSc, CTO & GM (Age 62, Pay $501.87k)Dr. Eyal Morag M.D., Chief Medical Officer & Member of Scientific Advisory Board (Age 57, Pay $567.06k)Prof. Moshe Shoham D.Sc., Co-Founder, Scientific Director & Chairman of Scientific Advisory Board (Age 70)Ms. Rachel Vaknin, Chief Financial Officer Who are some of Microbot Medical's key competitors? Some companies that are related to Microbot Medical include Taysha Gene Therapies (TSHA), Finch Therapeutics Group (FNCH), Genenta Science (GNTA), Armata Pharmaceuticals (ARMP), Compugen (CGEN), Passage Bio (PASG), Big Cypress Acquisition (BCYP), Cellectis (CLLS), Athira Pharma (ATHA), Oyster Point Pharma (OYST), Adverum Biotechnologies (ADVM), Axcella Health (AXLA), TCR2 Therapeutics (TCRR), Surrozen (SRZN) and BioAtla (BCAB). View all of MBOT's competitors. What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), Micron Technology (MU) and Sorrento Therapeutics (SRNE). What is Microbot Medical's stock symbol? Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT." How do I buy shares of Microbot Medical? Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Microbot Medical's stock price today? One share of MBOT stock can currently be purchased for approximately $5.01. How much money does Microbot Medical make? Microbot Medical (NASDAQ:MBOT) has a market capitalization of $35.61 million. The biotechnology company earns $-11.31 million in net income (profit) each year or ($1.420010) on an earnings per share basis. How many employees does Microbot Medical have? Microbot Medical employs 14 workers across the globe. When was Microbot Medical founded? Microbot Medical was founded in 2010. How can I contact Microbot Medical? Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The official website for Microbot Medical is www.microbotmedical.com. The biotechnology company can be reached via phone at (781) 875-3605, via email at [email protected], or via fax at 781-556-5347. This page (NASDAQ:MBOT) was last updated on 7/2/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
